Literature DB >> 22262351

The pathology of Mycobacterium tuberculosis infection.

K Sakamoto1.   

Abstract

Mycobacterium tuberculosis is an old enemy of the human race, with evidence of infection observed as early as 5000 years ago. Although more host-restricted than Mycobacterium bovis, which can infect all warm-blooded vertebrates, M. tuberculosis can infect, and cause morbidity and mortality in, several veterinary species as well. As M. tuberculosis is one of the earliest described bacterial pathogens, the literature describing this organism is vast and overwhelming. This review strives to distill what is currently known about this bacterium and the disease it causes for the veterinary pathologist.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22262351     DOI: 10.1177/0300985811429313

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  30 in total

1.  Anti-vascular endothelial growth factor treatment normalizes tuberculosis granuloma vasculature and improves small molecule delivery.

Authors:  Meenal Datta; Laura E Via; Walid S Kamoun; Chong Liu; Wei Chen; Giorgio Seano; Danielle M Weiner; Daniel Schimel; Kathleen England; John D Martin; Xing Gao; Lei Xu; Clifton E Barry; Rakesh K Jain
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-26       Impact factor: 11.205

Review 2.  Isoniazid and host immune system interactions: A proposal for a novel comprehensive mode of action.

Authors:  Saifur R Khan; Yousef Manialawy; Arno G Siraki
Journal:  Br J Pharmacol       Date:  2019-11-12       Impact factor: 8.739

3.  The effects of SP110's associated genes on fresh cavitary pulmonary tuberculosis in Han Chinese population.

Authors:  Shi-Yao Jiang; Lin-Lin Li; Jun Yue; Wen-Zhong Chen; Chao Yang; Chun-Ling Wan; Lin He; Lei Cai; Shao-Li Deng
Journal:  Clin Exp Med       Date:  2015-01-23       Impact factor: 3.984

Review 4.  Macrophages in Microbial Pathogenesis: Commonalities of Defense Evasion Mechanisms.

Authors:  Saurabh Pandey; Sashi Kant; Masuma Khawary; Deeksha Tripathi
Journal:  Infect Immun       Date:  2021-11-15       Impact factor: 3.609

5.  Mathematical Model of Oxygen Transport in Tuberculosis Granulomas.

Authors:  Meenal Datta; Laura E Via; Wei Chen; James W Baish; Lei Xu; Clifton E Barry; Rakesh K Jain
Journal:  Ann Biomed Eng       Date:  2015-08-08       Impact factor: 3.934

6.  Concordant or discordant results by the tuberculin skin test and the quantiFERON-TB test in children reflect immune biomarker profiles.

Authors:  S Dhanasekaran; S Jenum; R Stavrum; C Ritz; J Kenneth; M Vaz; T M Doherty; H M S Grewal
Journal:  Genes Immun       Date:  2014-04-17       Impact factor: 2.676

7.  Pharmacokinetics of rifapentine and rifampin in a rabbit model of tuberculosis and correlation with clinical trial data.

Authors:  Dalin Rifat; Brendan Prideaux; Radojka M Savic; Michael E Urbanowski; Teresa L Parsons; Brian Luna; Mark A Marzinke; Alvaro A Ordonez; Vincent P DeMarco; Sanjay K Jain; Veronique Dartois; William R Bishai; Kelly E Dooley
Journal:  Sci Transl Med       Date:  2018-04-04       Impact factor: 17.956

8.  Humoral and lung immune responses to Mycobacterium tuberculosis infection in a primate model of protection.

Authors:  Noton K Dutta; James McLachlan; Smriti Mehra; Deepak Kaushal
Journal:  Trials Vaccinol       Date:  2014-03-13

9.  Etanercept exacerbates inflammation and pathology in a rabbit model of active pulmonary tuberculosis.

Authors:  Liana Tsenova; Paul O'Brien; Jennifer Holloway; Blas Peixoto; Patricia Soteropoulos; Dorothy Fallows; Gilla Kaplan; Selvakumar Subbian
Journal:  J Interferon Cytokine Res       Date:  2014-05-15       Impact factor: 2.607

10.  Transmission of Mycobacterium tuberculosis from an Asian elephant (Elephas maximus) to a chimpanzee (Pan troglodytes) and humans in an Australian zoo.

Authors:  N Stephens; L Vogelnest; C Lowbridge; A Christensen; G B Marks; V Sintchenko; J McAnulty
Journal:  Epidemiol Infect       Date:  2013-03-28       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.